nodes	percent_of_prediction	percent_of_DWPC	metapath
Propericiazine—Pigmentation disorder—Prednisone—ankylosing spondylitis	0.0274	0.0274	CcSEcCtD
Propericiazine—Embolism venous—Prednisolone—ankylosing spondylitis	0.0249	0.0249	CcSEcCtD
Propericiazine—Embolism venous—Triamcinolone—ankylosing spondylitis	0.0229	0.0229	CcSEcCtD
Propericiazine—Embolism venous—Methylprednisolone—ankylosing spondylitis	0.0229	0.0229	CcSEcCtD
Propericiazine—Menstruation irregular—Prednisolone—ankylosing spondylitis	0.0227	0.0227	CcSEcCtD
Propericiazine—Menstruation irregular—Triamcinolone—ankylosing spondylitis	0.0209	0.0209	CcSEcCtD
Propericiazine—Menstruation irregular—Methylprednisolone—ankylosing spondylitis	0.0208	0.0208	CcSEcCtD
Propericiazine—Embolism venous—Dexamethasone—ankylosing spondylitis	0.0208	0.0208	CcSEcCtD
Propericiazine—Embolism venous—Betamethasone—ankylosing spondylitis	0.0208	0.0208	CcSEcCtD
Propericiazine—Menstruation irregular—Betamethasone—ankylosing spondylitis	0.019	0.019	CcSEcCtD
Propericiazine—Menstruation irregular—Dexamethasone—ankylosing spondylitis	0.019	0.019	CcSEcCtD
Propericiazine—Embolism venous—Prednisone—ankylosing spondylitis	0.0181	0.0181	CcSEcCtD
Propericiazine—Glaucoma—Prednisolone—ankylosing spondylitis	0.0167	0.0167	CcSEcCtD
Propericiazine—Menstruation irregular—Prednisone—ankylosing spondylitis	0.0165	0.0165	CcSEcCtD
Propericiazine—Glaucoma—Triamcinolone—ankylosing spondylitis	0.0154	0.0154	CcSEcCtD
Propericiazine—Glaucoma—Methylprednisolone—ankylosing spondylitis	0.0153	0.0153	CcSEcCtD
Propericiazine—Sudden death—Methotrexate—ankylosing spondylitis	0.0149	0.0149	CcSEcCtD
Propericiazine—Glaucoma—Betamethasone—ankylosing spondylitis	0.0139	0.0139	CcSEcCtD
Propericiazine—Glaucoma—Dexamethasone—ankylosing spondylitis	0.0139	0.0139	CcSEcCtD
Propericiazine—Amenorrhoea—Methylprednisolone—ankylosing spondylitis	0.0131	0.0131	CcSEcCtD
Propericiazine—Deep vein thrombosis—Methotrexate—ankylosing spondylitis	0.0126	0.0126	CcSEcCtD
Propericiazine—Glaucoma—Prednisone—ankylosing spondylitis	0.0121	0.0121	CcSEcCtD
Propericiazine—Amenorrhoea—Dexamethasone—ankylosing spondylitis	0.0119	0.0119	CcSEcCtD
Propericiazine—Amenorrhoea—Betamethasone—ankylosing spondylitis	0.0119	0.0119	CcSEcCtD
Propericiazine—Amenorrhoea—Prednisone—ankylosing spondylitis	0.0104	0.0104	CcSEcCtD
Propericiazine—Increased appetite—Prednisolone—ankylosing spondylitis	0.00972	0.00972	CcSEcCtD
Propericiazine—Increased appetite—Triamcinolone—ankylosing spondylitis	0.00893	0.00893	CcSEcCtD
Propericiazine—Increased appetite—Methylprednisolone—ankylosing spondylitis	0.00891	0.00891	CcSEcCtD
Propericiazine—Increased appetite—Dexamethasone—ankylosing spondylitis	0.00811	0.00811	CcSEcCtD
Propericiazine—Increased appetite—Betamethasone—ankylosing spondylitis	0.00811	0.00811	CcSEcCtD
Propericiazine—Sweating increased—Prednisolone—ankylosing spondylitis	0.00769	0.00769	CcSEcCtD
Propericiazine—Pulmonary embolism—Methotrexate—ankylosing spondylitis	0.00764	0.00764	CcSEcCtD
Propericiazine—Asthma—Triamcinolone—ankylosing spondylitis	0.00726	0.00726	CcSEcCtD
Propericiazine—Weight increased—Prednisolone—ankylosing spondylitis	0.00718	0.00718	CcSEcCtD
Propericiazine—Sweating increased—Triamcinolone—ankylosing spondylitis	0.00707	0.00707	CcSEcCtD
Propericiazine—Increased appetite—Prednisone—ankylosing spondylitis	0.00706	0.00706	CcSEcCtD
Propericiazine—Sweating increased—Methylprednisolone—ankylosing spondylitis	0.00705	0.00705	CcSEcCtD
Propericiazine—Hypokalaemia—Betamethasone—ankylosing spondylitis	0.00693	0.00693	CcSEcCtD
Propericiazine—Hypokalaemia—Dexamethasone—ankylosing spondylitis	0.00693	0.00693	CcSEcCtD
Propericiazine—Gynaecomastia—Methotrexate—ankylosing spondylitis	0.00683	0.00683	CcSEcCtD
Propericiazine—Weight increased—Triamcinolone—ankylosing spondylitis	0.0066	0.0066	CcSEcCtD
Propericiazine—Weight increased—Methylprednisolone—ankylosing spondylitis	0.00659	0.00659	CcSEcCtD
Propericiazine—Sweating increased—Dexamethasone—ankylosing spondylitis	0.00641	0.00641	CcSEcCtD
Propericiazine—Sweating increased—Betamethasone—ankylosing spondylitis	0.00641	0.00641	CcSEcCtD
Propericiazine—Photosensitivity—Methotrexate—ankylosing spondylitis	0.00631	0.00631	CcSEcCtD
Propericiazine—Hypokalaemia—Prednisone—ankylosing spondylitis	0.00604	0.00604	CcSEcCtD
Propericiazine—Weight increased—Betamethasone—ankylosing spondylitis	0.00599	0.00599	CcSEcCtD
Propericiazine—Weight increased—Dexamethasone—ankylosing spondylitis	0.00599	0.00599	CcSEcCtD
Propericiazine—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.00594	0.00594	CcSEcCtD
Propericiazine—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	0.00594	0.00594	CcSEcCtD
Propericiazine—Arrhythmia—Prednisolone—ankylosing spondylitis	0.00564	0.00564	CcSEcCtD
Propericiazine—Sweating increased—Prednisone—ankylosing spondylitis	0.00558	0.00558	CcSEcCtD
Propericiazine—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.00538	0.00538	CcSEcCtD
Propericiazine—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.00528	0.00528	CcSEcCtD
Propericiazine—Weight increased—Prednisone—ankylosing spondylitis	0.00522	0.00522	CcSEcCtD
Propericiazine—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.00519	0.00519	CcSEcCtD
Propericiazine—Vision blurred—Prednisolone—ankylosing spondylitis	0.00518	0.00518	CcSEcCtD
Propericiazine—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.00518	0.00518	CcSEcCtD
Propericiazine—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.00517	0.00517	CcSEcCtD
Propericiazine—Angioedema—Prednisolone—ankylosing spondylitis	0.00502	0.00502	CcSEcCtD
Propericiazine—Asthma—Methotrexate—ankylosing spondylitis	0.00479	0.00479	CcSEcCtD
Propericiazine—Eosinophilia—Methotrexate—ankylosing spondylitis	0.00474	0.00474	CcSEcCtD
Propericiazine—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.00471	0.00471	CcSEcCtD
Propericiazine—Arrhythmia—Betamethasone—ankylosing spondylitis	0.00471	0.00471	CcSEcCtD
Propericiazine—Angioedema—Triamcinolone—ankylosing spondylitis	0.00462	0.00462	CcSEcCtD
Propericiazine—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00461	0.00461	CcSEcCtD
Propericiazine—Oedema—Prednisolone—ankylosing spondylitis	0.00449	0.00449	CcSEcCtD
Propericiazine—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.00441	0.00441	CcSEcCtD
Propericiazine—Tachycardia—Prednisolone—ankylosing spondylitis	0.00438	0.00438	CcSEcCtD
Propericiazine—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.00437	0.00437	CcSEcCtD
Propericiazine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00434	0.00434	CcSEcCtD
Propericiazine—Pneumonia—Methotrexate—ankylosing spondylitis	0.0043	0.0043	CcSEcCtD
Propericiazine—Drowsiness—Methotrexate—ankylosing spondylitis	0.00427	0.00427	CcSEcCtD
Propericiazine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00421	0.00421	CcSEcCtD
Propericiazine—Angioedema—Dexamethasone—ankylosing spondylitis	0.00419	0.00419	CcSEcCtD
Propericiazine—Angioedema—Betamethasone—ankylosing spondylitis	0.00419	0.00419	CcSEcCtD
Propericiazine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00415	0.00415	CcSEcCtD
Propericiazine—Oedema—Triamcinolone—ankylosing spondylitis	0.00413	0.00413	CcSEcCtD
Propericiazine—Arrhythmia—Prednisone—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Propericiazine—Infection—Triamcinolone—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Propericiazine—Infection—Methylprednisolone—ankylosing spondylitis	0.00409	0.00409	CcSEcCtD
Propericiazine—Insomnia—Prednisolone—ankylosing spondylitis	0.00406	0.00406	CcSEcCtD
Propericiazine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00403	0.00403	CcSEcCtD
Propericiazine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00402	0.00402	CcSEcCtD
Propericiazine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00399	0.00399	CcSEcCtD
Propericiazine—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00399	0.00399	CcSEcCtD
Propericiazine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00398	0.00398	CcSEcCtD
Propericiazine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00385	0.00385	CcSEcCtD
Propericiazine—Vision blurred—Prednisone—ankylosing spondylitis	0.00376	0.00376	CcSEcCtD
Propericiazine—Oedema—Dexamethasone—ankylosing spondylitis	0.00374	0.00374	CcSEcCtD
Propericiazine—Oedema—Betamethasone—ankylosing spondylitis	0.00374	0.00374	CcSEcCtD
Propericiazine—Insomnia—Triamcinolone—ankylosing spondylitis	0.00373	0.00373	CcSEcCtD
Propericiazine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00372	0.00372	CcSEcCtD
Propericiazine—Infection—Dexamethasone—ankylosing spondylitis	0.00372	0.00372	CcSEcCtD
Propericiazine—Infection—Betamethasone—ankylosing spondylitis	0.00372	0.00372	CcSEcCtD
Propericiazine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00368	0.00368	CcSEcCtD
Propericiazine—Agitation—Prednisone—ankylosing spondylitis	0.00367	0.00367	CcSEcCtD
Propericiazine—Tachycardia—Betamethasone—ankylosing spondylitis	0.00365	0.00365	CcSEcCtD
Propericiazine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00365	0.00365	CcSEcCtD
Propericiazine—Angioedema—Prednisone—ankylosing spondylitis	0.00365	0.00365	CcSEcCtD
Propericiazine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00362	0.00362	CcSEcCtD
Propericiazine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00362	0.00362	CcSEcCtD
Propericiazine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00356	0.00356	CcSEcCtD
Propericiazine—Hypotension—Betamethasone—ankylosing spondylitis	0.0035	0.0035	CcSEcCtD
Propericiazine—Hypotension—Dexamethasone—ankylosing spondylitis	0.0035	0.0035	CcSEcCtD
Propericiazine—Insomnia—Dexamethasone—ankylosing spondylitis	0.00339	0.00339	CcSEcCtD
Propericiazine—Insomnia—Betamethasone—ankylosing spondylitis	0.00339	0.00339	CcSEcCtD
Propericiazine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00331	0.00331	CcSEcCtD
Propericiazine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00326	0.00326	CcSEcCtD
Propericiazine—Oedema—Prednisone—ankylosing spondylitis	0.00326	0.00326	CcSEcCtD
Propericiazine—Infection—Prednisone—ankylosing spondylitis	0.00324	0.00324	CcSEcCtD
Propericiazine—Tachycardia—Prednisone—ankylosing spondylitis	0.00318	0.00318	CcSEcCtD
Propericiazine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00315	0.00315	CcSEcCtD
Propericiazine—Vision blurred—Methotrexate—ankylosing spondylitis	0.00315	0.00315	CcSEcCtD
Propericiazine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00304	0.00304	CcSEcCtD
Propericiazine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00303	0.00303	CcSEcCtD
Propericiazine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00296	0.00296	CcSEcCtD
Propericiazine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00296	0.00296	CcSEcCtD
Propericiazine—Insomnia—Prednisone—ankylosing spondylitis	0.00295	0.00295	CcSEcCtD
Propericiazine—Rash—Prednisolone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Propericiazine—Dermatitis—Prednisolone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Propericiazine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Propericiazine—Constipation—Prednisone—ankylosing spondylitis	0.00279	0.00279	CcSEcCtD
Propericiazine—Confusional state—Methotrexate—ankylosing spondylitis	0.00275	0.00275	CcSEcCtD
Propericiazine—Infection—Methotrexate—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Propericiazine—Nausea—Prednisolone—ankylosing spondylitis	0.00266	0.00266	CcSEcCtD
Propericiazine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Propericiazine—Vomiting—Triamcinolone—ankylosing spondylitis	0.00262	0.00262	CcSEcCtD
Propericiazine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00262	0.00262	CcSEcCtD
Propericiazine—Rash—Triamcinolone—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Propericiazine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Propericiazine—Rash—Methylprednisolone—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Propericiazine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00259	0.00259	CcSEcCtD
Propericiazine—Body temperature increased—Prednisone—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Propericiazine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Propericiazine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Propericiazine—Hypotension—Methotrexate—ankylosing spondylitis	0.00255	0.00255	CcSEcCtD
Propericiazine—Insomnia—Methotrexate—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Propericiazine—Nausea—Triamcinolone—ankylosing spondylitis	0.00245	0.00245	CcSEcCtD
Propericiazine—Nausea—Methylprednisolone—ankylosing spondylitis	0.00245	0.00245	CcSEcCtD
Propericiazine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00243	0.00243	CcSEcCtD
Propericiazine—Somnolence—Methotrexate—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Propericiazine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Propericiazine—Vomiting—Betamethasone—ankylosing spondylitis	0.00238	0.00238	CcSEcCtD
Propericiazine—Vomiting—Dexamethasone—ankylosing spondylitis	0.00238	0.00238	CcSEcCtD
Propericiazine—Rash—Dexamethasone—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Propericiazine—Rash—Betamethasone—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Propericiazine—Dermatitis—Betamethasone—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Propericiazine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Propericiazine—Diarrhoea—Prednisone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Propericiazine—Nausea—Betamethasone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Propericiazine—Nausea—Dexamethasone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Propericiazine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Propericiazine—Vomiting—Prednisone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Propericiazine—Rash—Prednisone—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Propericiazine—Dermatitis—Prednisone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Propericiazine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Propericiazine—Nausea—Prednisone—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Propericiazine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Propericiazine—Vomiting—Methotrexate—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Propericiazine—Rash—Methotrexate—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Propericiazine—Dermatitis—Methotrexate—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Propericiazine—Nausea—Methotrexate—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
